Supernus Pharmaceuticals (SUPN) PT Lowered to $50 at Cowen

August 7, 2019 10:32 AM

Cowen analyst Ken Cacciatore lowered the price target on Supernus Pharmaceuticals (NASDAQ: SUPN) to $50.00 (from $55.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found